Imipenem is a member of a new class of highly potent P-lactam antibiotics, carbapenems, with an antibacterial spectrum that includes nearly all currently known aerobic and anaerobic bacterial species of clinical significance. Although relatively stable in most standard laboratory media used for antimicrobial susceptibility testing, imipenem undergoes rapid inactivation in thioglycolate broth, a recommended medium for susceptibility testing of anaerobic bacteria by the broth disk method. In the current study, a panel of 36 anaerobic bacteria consisting of 28 clinical isolates and eight quality control strains was used to determine the suitability and accuracy of the broth disk methods with brain heart infusion, Schaedler, and anaerobic broths, in comparison to the reference agar dilution method, for the anaerobic susceptibility testing of imipenem. To achieve single test concentrations of approximately 8, 16, and 64 ,ug/ml for imipenem, cefoxitin, and piperacillin, respectively, which correspond to the MIC breakpoints of the test drugs, four 10-,Ig imipenem disks, three 30-,Lg cefoxitin disks, and three 100-,ug piperacillin disks were used in 5 ml of broth. The correlation between the reference agar dilution method and each of the three broth disk elution procedures evaluated was excellent, for imipenem (100% agreement) and somewhat less so for cefoxitin and piperacillin. Therefore, brain heart infusion, Schaedler, and anaerobic broths, but not thioglycolate broth, are suitable for anaerobic susceptibility testing of imipenem by the disk elution method.
The clinical significance of anaerobic infections has gained increasing recognition during the last two decades. The reported decrease in the predictability of the susceptibility patterns of anaerobes to existing antibacterial agents has clearly underscored the need for frequent in vitro susceptibility testing of these microorganisms (10) . Of the three currently approved methods of testing, namely, the agar dilution, the broth dilution, and the broth disk elution methods, the disk elution method is the simplest, most cost effective and practical, and therefore most popular, especially among small clinical laboratories (10, 14) . This technique involves testing only one concentration of each antibacterial agent, that concentration which corresponds to the expected therapeutic level of the test compound in serum. The broth disk test as first described by Wilkins and Thiel (14) uses prereduced and supplemented brain heart infusion broth (BHI-B). Since this method requires the use of oxygen-free CO2 or anaerobic chambers, a similar but simpler system that uses thioglycolate broth and aerobic incubation was introduced by Kurzynski and co-workers (5) and is being used by a substantial number of clinical laboratories.
The increased potency and the unusually broad antibacterial spectrum of imipenem (N-formimidoyl thienamycin, MK0787) in comparison to those of other P-lactam antibiotics have been well documented (3, 9) . Nearly all data presently available on the in vitro activity of imipenem against anaerobic bacteria have been derived by the reference agar dilution method (1, 2, 6, 8) . A preliminary investigation in our laboratory has shown that imipenem sustains a substantial loss of in vitro activity in thioglycolate, i.e., more than 90% inactivation in 6 h (unpublished data). In other studies, imipenem (12) and penicillins (7) (5 g), glucose (5.82 g), sodium chloride (1.7 g), dipotassium phosphate (0.82 g), Tris (3 g), hemin (10 mg), and L-cystine (0.4 g). BHI-B contained (per liter of distilled water) calf brain infusion (200 g), beef heart infusion (250 g), Proteose Peptone (10 g; Difco), yeast extract (5 g), glucose (2 g), sodium chloride (5 g), and disodium phosphate (2.5 g). The thioglycolate medium contained (per liter of distilled water) Trypticase Peptone (17 g) (BBL), Phytone Peptone (3 g; BBL), glucose (6 g), sodium chloride (2.5 g), sodium thioglycolate (0.5 g), L-cystine (0.25 g), sodium sulfite (0.1 g), and agar (0.7 g). Each of these three media was supplemented with hemin (5 jig/ml) and vitamin K1 (0.1 jig/ml). The thioglycolate medium also was supplemented with sodium bicarbonate (1 mg/ml (greater than 50% of the turbidity of the untreated control; resistant), or ± (ca. 50% of the turbidity of the growth control; or intermediate).
RESULTS AND DISCUSSION
The data (Table 1) for the broth macrodilution test with B. fragilis ATCC 25285, B. thetaiotaomicron ATCC 29742, and C. perfringens ATCC 13124 show a significant decrease, by at least 64-fold, in the antibacterial activity of imipenem in the thioglycolate medium versus the anaerobic broth. In addition, the qualitative results from the broth disk test with the same media and the same reference strains agree completely with the MIC data. These results suggest that at the level of 0.5 mg/ml or 4 mM normally included in the thioglycolate broth, sodium thioglycolate is capable of causing substantial inactivation of imipenem. This phase of the study clearly confirms the unsuitability of thioglycolate broth for testing the susceptibility of anaerobes to imipenem.
The results of the anaerobic susceptibility testing of imipenem, cefoxitin, and piperacillin by three broth disk methods compared with the reference agar dilution method are MIC of 64 pg/ml and for three clostridial strains (two C. difficile and one C. tertium) with MICs of 2 p.g/ml, all the remaining test strains had MICs of imipenem of .0.5 jig/ml. B. fragilis CLA 68 was a special isolate received from Tufts-New England Medical Center, Boston, Mass., and was deliberately included in this study because of its known resistance to a variety of antibiotics, including imipenem. To more accurately evaluate an antibacterial agent by the broth disk method for anaerobic activity, it is necessary to include organisms with MICs near the susceptible and resistant MIC breakpoints of the test drug. For imipenem, inclusion in this study of bacterial isolates with MICs in the range of 4 to 16 jig/ml would have been highly desirable. However, a review of the literature coupled with several personal communications with some investigators in the field who have tested imipenem suggest that such strains still are extremely difficult to find.
The correlation among the results obtained by the various testing procedures was also quite good for cefoxitin: 75% of the bacterial strains tested were susceptible by the agar dilution method and 69.4, 66.7, and 69.4% were susceptible by the broth disk test with using BHI-B, anaerobic broth, and Schaedler broth, respectively. Seven of the nine test cultures shown to be resistant to cefoxitin (MIC, .32 ,ug/ml) by the agar dilution test also were resistant to this drug by all three broth disk methods. The other two cultures B. thetaiotaomicron CLA 235 and B. thetaiotaomicron ATCC 29742 yielded intermediate results in Schaedler broth. It should be pointed out that since a study such as the one reported here requires a deliberate inclusion of both susceptible and resistant bacterial isolates, the computed rates of susceptible strains, i.e., 66.7 to 75% for cefoxitin, appear somewhat lower than what would be expected under normal conditions, i.e., >80% for cefoxitin (11 (Table 2) suggests that the antibacterial property of imipenem is not noticeably affected by the low level of Tris normally contained in this medium.
It can be concluded from the data herein presented that BHI-B, Schaedler broth, and anaerobic broth can and should be used instead of thioglycolate broth in the broth disk method for in vitro susceptibility testing of anaerobic bacteria to imipenem. However, unlike the aerobically incubated thioglycolate broth (5), the three broth disk test systems evaluated in this study require, as usual, anaerobic incubation or a variation thereof (13) .
